January 24, 2019

Etiology of Mitral Valve Disease: What’s the Impact of Sex and Time?

Despite shifts in etiology over time, sex differences persist

In the developed world, the etiology of surgically treated mitral valve disease has shifted over the past three decades from sizeable numbers of rheumatic and ischemic cases to a greater predominance of degenerative disease. This shift has helped spur growth in mitral valve repair and a decline in mitral valve replacement as surgeons’ ability to reconstruct degenerative valves has continued to improve.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Despite these trends, female patients undergo mitral valve replacement at higher rates than their male counterparts do, and this has been linked to persistently poorer outcomes of mitral valve surgery in women.

Studies to date generally have not accounted for sex differences in the etiology of surgical mitral valve disease or any changes in etiology over time, so researchers from Cleveland Clinic recently set out to address that gap by analyzing a large series of patients undergoing primary mitral valve operations from the institution’s Cardiovascular Information Registry.

The analysis, published in Circulation (2018;138:1749-1751), included 23,806 consecutive patients from 1993 to 2016 who underwent primary mitral valve replacement or repair. Patients who had concomitant coronary artery bypass or another valve operation were included, but those with prior cardiac surgery were excluded. Findings of interest included the prevalence of various mitral valve disease etiologies as stratified by patient sex and also over time (by five-year intervals). Key findings are presented in the graphs below.

Advertisement

The researchers called attention to several notable observations:

  • Between-sex differences in prevalence of the three main disease types — degenerative, ischemic and rheumatic — were highly statistically significant (P < .001), with much higher rates of rheumatic disease in women and much higher rates of degenerative disease in men.
  • Prevalence of degenerative disease rose significantly over time, while prevalence of ischemic and rheumatic disease declined significantly over time (P < .001 for all).
  • Despite the changes in etiology prevalences over time, the between-sex differences in prevalence of each of the three main disease types remained consistently statistically significant over the entire 24-year study period.

“Our analysis clarifies that, despite a temporal shift in etiology of surgically treated mitral valve disease for patients overall, differences between the sexes persist into the modern era of cardiac surgery,” notes corresponding author Leslie Cho, MD, Director of Cleveland Clinic’s Women’s Cardiovascular Center.

Advertisement

“In demonstrating clear sex differences in the etiology of mitral valve disease, we’ve identified another potential explanation for sex differences in procedure selection and outcomes,” adds co-author A. Marc Gillinov, MD, Chair of Thoracic and Cardiovascular Surgery.

Related Articles

x-ray of bone fracture in a forearm
March 1, 2024
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism

Surprise findings argue for caution about testosterone use in men at risk for fracture

photo of intubated elderly woman in hospital bed
February 23, 2024
Proteomic Study Characterizes Markers of Frailty in Cardiovascular Disease and Their Links to Outcomes

Findings support emphasis on markers of frailty related to, but not dependent on, age

GettyImages-1252287413 [Converted]
September 8, 2023
Black Residents of Historically Redlined Areas Have Increased Heart Failure Risk

Large database study reveals lingering health consequences of decades-old discrimination

23-HVI-4172009 CQD 650&#215;450-2
August 29, 2023
Updates From CLEAR Outcomes and VALOR-HCM: Expanded Benefits With Bempedoic Acid and Mavacamten

Additional analyses of the two trials presented at 2023 ESC Congress

21-HVI-2577809_septal-myectomy-LVOTO-repair_650x450
January 6, 2022
Study Confirms Quality-of-Life Benefits of Myectomy in Obstructive HCM

Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up

21-HVI-2211308 gender-scales_650x450
August 10, 2021
8 Ways to Increase Women’s Participation in Cardiovascular Trials

An ACC committee issues recommendations to accelerate sluggish progress

20-HVI-1998312_carotid-endarterectomy_650x450
December 4, 2020
Carotid Endarterectomy and the High-Risk Patient

Review of our recent experience shows it’s still a safe option

20-HVI-2006253-artificial-intelligence-heart-research_650x450
November 30, 2020
AI Looms Large in New Studies of Heart Transplant Rejection and Noncompaction Cardiomyopathy

Machine learning may improve risk prediction and guide therapy

Ad